Anti-Cancer treatment targets activated platelets in tumor microenvironment
A novel chemotherapeutic agent transport system is based on the binding of an antibody-drug conjugate specifically directed to an exterior protein on energizing platelets in the tumor microenvironment. Based on the premise that platelets in the blood are progressively conceding as mediators of tumor swelling and metastasis, investigators at the Baker Heart and Diabetes Institute […]